Sandbox DL

Bone or Cartilage Mass Microchapters
Home
Patient Information
Overview
Classification
Causes
Differential Diagnosis
Epidemiology and Demographics
Screening
Diagnosis
Evaluation of Bone or Cartilage Mass
Staging
History and Symptoms
Physical Examination
Laboratory Studies
Imaging
Biopsy
Other Diagnostic Studies
Case Studies
Case #1
Sandbox DL On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sandbox DL All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sandbox DL
CDC on Sandbox DL
Sandbox DL in the news
Blogs on Sandbox DL
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Sandbox DL

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac

Staging

'Tumor Staging

Grade	G0	Benign
	G1	Low grade malignant
	G2	High grade malignant
Anatomic site	T0	Intracapsular
	T1	Extracapsular, intracompartmental
	T2	Extracapsular, extracompartmental
Metastasis	M0	No metastasis
	M1	Distant metastasis

! style="width: 180px;background: #4479BA" | Origin ! style="width: 120px;background: #4479BA" | Stages ! style="width: 120px;background: #4479BA" | Grade ! style="width: 120px;background: #4479BA" | Site ! style="width: 120px;background: #4479BA" | Metastasis ! style="width: 120px;background: #4479BA" | Description ! style="width: 120px;background: #4479BA" | Examples |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign | style="width: 120px;font-weight: bold;background: #DCDCDC" | 1 | style="background: #F5F5F5; text-align:center" | G0 | style="background: #F5F5F5; text-align:center" | T0 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | Benign latent | style="background: #F5F5F5; text-align:center" | Osteoid osteoma, lipoma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign | style="width: 120px;font-weight: bold;background: #DCDCDC" | 2 | style="background: #F5F5F5; text-align:center" | G0 | style="background: #F5F5F5; text-align:center" | T0 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | Benign active | style="background: #F5F5F5; text-align:center" | Giant cell tumor, hemangioma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign | style="width: 120px;font-weight: bold;background: #DCDCDC" | 3 | style="background: #F5F5F5; text-align:center" | G0 | style="background: #F5F5F5; text-align:center" | T1-T2 | style="background: #F5F5F5; text-align:center" | M0-M1 | style="background: #F5F5F5; text-align:center" | Benign aggresive | style="background: #F5F5F5; text-align:center" | Desmoplastic fibroma, chondroblastoma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IA | style="background: #F5F5F5; text-align:center" | G1 | style="background: #F5F5F5; text-align:center" | T1 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | Low grade malignant, intracompartmental | style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, dematofibrosarcoma protuberans |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IB | style="background: #F5F5F5; text-align:center" | G1 | style="background: #F5F5F5; text-align:center" | T2 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | Low grade malignant, extracompartmental | style="background: #F5F5F5; text-align:center" | Parosteal osteosarcoma, hemangioendothelioma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IIA | style="background: #F5F5F5; text-align:center" | G2 | style="background: #F5F5F5; text-align:center" | T1 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | High grade malignant, intracompartmental | style="background: #F5F5F5; text-align:center" | High grade central osteosarcoma, angiomatoid malignant fibrous histiocytoma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IIB | style="background: #F5F5F5; text-align:center" | G2 | style="background: #F5F5F5; text-align:center" | T2 | style="background: #F5F5F5; text-align:center" | M0 | style="background: #F5F5F5; text-align:center" | High grade malignant, extracompartmental | style="background: #F5F5F5; text-align:center" | Ewing sarcoma, high grade osteosarcoma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIA | style="background: #F5F5F5; text-align:center" | G1-G2 | style="background: #F5F5F5; text-align:center" | T1 | style="background: #F5F5F5; text-align:center" | M1 | style="background: #F5F5F5; text-align:center" | Regional metastasis | style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, low grade synovial sarcoma |- | style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant | style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIB | style="background: #F5F5F5; text-align:center" | G1-G2 | style="background: #F5F5F5; text-align:center" | T2 | style="background: #F5F5F5; text-align:center" | M1 | style="background: #F5F5F5; text-align:center" | Distant metastasis | style="background: #F5F5F5; text-align:center" | High grade osteosarcoma, high grade liposarcoma |}